Philips' Direct-to-Angio Stroke Pathway: New Analysis Demonstrates Substantial Cost Savings in Addition to Improved Patient Outcomes
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an innovative approach to the stroke care pathway reduced costs by an average of EUR 2,848 (~USD 3,120) per patient. The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain) 
NHS trusts need a lot of technology, but they face complex, structural challenges when it comes to procurement, and these tend to work against smaller companies and innovation. The Highland Marketing advisory board met recently to discuss the issues and the role of marketing. 
Nurses and doctors at South Tees Hospitals NHS Foundation Trust have remarked on substantial time savings and safer ways of working, just hours after the go-live of a new digital noting solution.
Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety. 
Siemens Healthineers is building a new factory in Forchheim for the cultivation of crystals for semiconductor production. The total investment amounts to 80 million euros. The new factory is expected to create 100 new jobs. The existing production facility in Japan is reaching its capacity limits. The crystals are used as detector material for the latest generation of CT scanners.